Arcutis Biotherapeutics Inc (ARQT) USD0.0001
1.30%- This stock can be held in a
Stocks and Shares ISASell:$13.43
Buy:$13.44
Change:
$0.07
(0.52%)
$0.07
(0.52%)Market closed | Prices delayed by at least 15 minutes
Sell:$13.43
Buy:$13.44
Change:$0.07
(0.52%)
$0.07
(0.52%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 5 June 2025 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 378 | $13.41 | $5,069.28 | 24,802 |
| 4 June 2025 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 1,890 | $13.32 | $25,177.45 | 24,424 |
| 28 May 2025 | Masaru (Mas) MatsudaCompany Secretary | Sell Tax related | 1,800 | $13.78 | $24,806.52 | 202,599 |
| 22 May 2025 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 2,520 | $13.65 | $34,398.00 | 22,534 |
| 21 May 2025 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 2,520 | $13.66 | $34,423.20 | 20,014 |
| 19 May 2025 | Larry Todd EdwardsChief Level Officer | Sell Tax related | 7,451 | $14.07 | $104,849.73 | 183,104 |
| 15 May 2025 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 2,520 | $13.62 | $34,316.86 | 17,494 |
| 14 May 2025 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 6,300 | $13.76 | $86,691.15 | 14,974 |
| 13 May 2025 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 2,374 | $13.76 | $32,660.78 | 8,674 |
| 9 May 2025 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 6,300 | $13.60 | $85,691.34 | 6,300 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 March 2025 | Patrick BurnettOther Level A | Sell Regular sell transaction (market) | 44,153 | $14.97 | $660,771.72 | 121,936 |
| 14 November 2024 | Patrick BurnettOther Level A | Sell Regular sell transaction (market) | 50,749 | $10.29 | $522,435.58 | 128,669 |
| 3 March 2025 | Todd Franklin WatanabePresident/CEO | Sell Tax related | 20,880 | $13.03 | $272,089.37 | 934,249 |
| 3 February 2025 | Todd Franklin WatanabePresident/CEO | Sell Tax related | 19,301 | $12.70 | $245,122.70 | 804,129 |
| 20 December 2024 | Todd Franklin WatanabePresident/CEO | Sell Regular sell transaction (market) | 15,000 | $15.17 | $227,566.50 | 823,430 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.